Dr. Axe Wire · Study decoded · sleep

Sleep-Linked Depression Subtype Tied to Weaker Antidepressant Response in 2,604 Adults

A sleep-pattern-based depression subtype was linked to earlier onset, weight gain, and lower odds of responding to standard antidepressants.

By Dr. Josh Axe · November 10, 2026 · 2 sources · Watch

Photo: Pexels

A circadian subtype of depression, marked by disrupted sleep and body-clock patterns, was linked to earlier onset, more severe symptoms and weaker response to standard antidepressants, in a study first published October 20, 2026 in The British Journal of Psychiatry.

23%had this subtype

12%lower SSRI response

11%lower SNRI response

Researchers analyzed data from the nationwide Australian Genetics of Depression Study and identified 2,604 participants, 23% of the sample, who met criteria for a circadian subtype of depression: at least three of six features including social jetlag, seasonal mood changes, a delayed sleep midpoint, an evening chronotype, morning tiredness or hypersomnia. This group was 80% female, average age 37.9.

Compared with people whose depression did not fit this pattern, the circadian subtype group reported an earlier age of onset, more severe symptoms including psychotic-like and manic-like experiences, suicidality, psychological distress and physical complaints, plus weight gain during depressive episodes. Self-reported SSRI response was 12% lower (odds ratio 0.88) and SNRI response was 11% lower (odds ratio 0.89), with more side effects overall.

The circadian subtype carried higher genetic risk scores across several conditions: ADHD (11% higher odds), major depression (11% higher), anxiety (10% higher), bipolar disorder (9% higher), higher body mass index (9% higher), triglycerides (10% higher), the immune-signaling marker interleukin-6 (8% higher) and insulin resistance (8% higher). This group's depression pattern lined up with genetic risk spanning mood, metabolism and inflammation, not sleep genetics alone. The authors describe this as evidence the circadian subtype has biological validity as a distinct clinical profile.

Antidepressant Response: Circadian Subtype vs Other Depression

British Journal of Psychiatry, 2026, Tonini et al.

Data were cross-sectional and self-reported, with medication response based on recall rather than clinical records, showing a link between sleep patterns and treatment response, not proof that disrupted circadian rhythms cause the weaker result. The authors call for independent replication before this changes clinical care.

Dr. Axe’s Take

The root issue here isn't a missing drug, it's a body clock that's out of sync, and no antidepressant dose fixes that on its own. SSRIs and SNRIs work on brain chemistry; they don't reset when someone eats, sleeps, or sees light, which this study found tracks with a weaker response and more side effects in this group. What I'd watch for is a pattern of poor response to a first antidepressant paired with a late, irregular sleep schedule, worth naming at the next appointment. Keep taking any prescribed medication, and make changes only with your prescriber, based on your numbers.

— Dr. Axe

Take the Cortisol Quiz →

Study summary

Who: 2,604 of 11,326 Australian adults with depression (23%), 80% female, average age 37.9.
Design: Cross-sectional analysis, Australian Genetics of Depression Study; published 2026-10-20.
Dose: Not applicable (observational classification study, no intervention tested).
Primary result: Circadian subtype linked to 12% lower SSRI response (OR 0.88) and 11% lower SNRI response (OR 0.89).
Secondary: Higher genetic risk scores: ADHD +11%, major depression +11%, anxiety +10%, bipolar disorder +9%, BMI +9%, triglycerides +10%, interleukin-6 +8%, insulin resistance +8%.
Funding / conflicts: Funding and conflicts not reported in the abstract.
Date: Oct 20, 2026